During the past decade, Georgia Cancer Specialists conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 24 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 13 clinical trials were completed. i.e. 433.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgia Cancer Specialists" #1 sponsor was "Pfizer" with 8 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Celgene" with 3 trials sponsored, "G1 Therapeutics, Inc." with 3 trials sponsored and "Seagen Inc." with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Cancer Specialists" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Breast Cancer Research Foundation" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Cancer Specialists" are "Breast Cancer" (10 trials), "Colorectal Cancer" (5 trials), "Lung Cancer" (3 trials), "Non-Small Cell Lung Cancer" (3 trials) and "Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Georgia Cancer Specialists" in a lesser frequency.

Most popular intervention types in "Georgia Cancer Specialists" are "Drug" (50 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Docetaxel" (5 trials), "Doxorubicin" (4 trials), "Atezolizumab" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Cancer Specialists" are 49 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Georgia Cancer Specialists". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Georgia Cancer Specialists, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Cancer Specialists, 10 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Georgia Cancer Specialists has several departments that took part in Clinical trials: "Georgia Cancer Specialists" - 5 trials, "Georgia Cancer Specialists - Macon" - 5 trials, "Georgia Cancer Specialists - Kennestone" - 3 trials, "Georgia Cancer Specialists-Administrative Annex" - 2 trials